儿童淋巴管瘤：用玉米醇溶蛋白酒精溶液进行经皮硬化治疗
Lymphangiomas in children: percutaneous sclerotherapy with an alcoholic solution of zein.
作者信息
Dubois J, Garel L, Abela A, Laberge L, Yazbeck S
机构信息
Department of Medical Imaging, Hôpital Sainte-Justine, Montréal, Québec, Canada.
出版信息
Radiology. 1997 Sep;204(3):651-4. doi: 10.1148/radiology.204.3.9280239.
PURPOSE
To determine the efficacy of percutaneous sclerotherapy with an alcoholic solution of zein in lymphangiomas in pediatric patients.
MATERIALS AND METHODS
Fourteen patients with macrocystic and mixed lymphangiomas were treated with use of Ethibloc as a sclerosing agent. The procedure was performed with ultrasonographic and/or fluoroscopic guidance. Follow-up clinical and sequential computed tomographic examinations were performed to evaluate regression of the lesion.
RESULTS
Regression was excellent in nine (64%) of the 14 lesions: Regression was complete in four lymphangiomas and was to less than 5% of the initial volume in five. Satisfactory results were obtained in the remaining five (36%) of 14 lesions. The most frequent complication was leakage of Ethibloc without important sequelae in 10 of the 14 lymphangiomas.
CONCLUSION
Percutaneous sclerotherapy with Ethibloc was a safe and effective procedure in the treatment of macrocystic and mixed lymphangiomas.
目的
确定使用玉米醇溶蛋白酒精溶液进行经皮硬化治疗小儿淋巴管瘤的疗效。
材料与方法
14例患有大囊型和混合型淋巴管瘤的患者接受了Ethibloc作为硬化剂的治疗。该操作在超声和/或荧光镜引导下进行。进行随访临床检查和连续计算机断层扫描以评估病变的消退情况。
结果
14个病变中有9个（64%）消退情况极佳：4个淋巴管瘤完全消退，5个消退至初始体积的不到5%。其余5个（36%）病变取得了满意的结果。最常见的并发症是Ethibloc渗漏，14个淋巴管瘤中有10个未出现严重后遗症。
结论
使用Ethibloc进行经皮硬化治疗是治疗大囊型和混合型淋巴管瘤的一种安全有效的方法。
Zotero 插件